Remifentanil Teva 2 mg inj./inf. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

remifentanil teva 2 mg inj./inf. sol. (pwdr., conc.) i.v. vial

teva pharma belgium sa-nv - remifentanil hydrochloride 2,2 mg - eq. remifentanil 2 mg - powder for concentrate for solution for injection/infusion - 2 mg - remifentanil hydrochloride 2.2 mg - remifentanil

Remifentanil Teva 5 mg inj./inf. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

remifentanil teva 5 mg inj./inf. sol. (pwdr., conc.) i.v. vial

teva pharma belgium sa-nv - remifentanil hydrochloride 5,5 mg - eq. remifentanil 5 mg - powder for concentrate for solution for injection/infusion - 5 mg - remifentanil hydrochloride 5.5 mg - remifentanil

Sufentanil Viatris 5 µg/ml inj. sol. i.v./epidur. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sufentanil viatris 5 µg/ml inj. sol. i.v./epidur. amp.

viatris gx bv-srl - sufentanil citrate 7,48 µg/ml - eq. sufentanil 5 µg/ml - solution for injection - 5 µg/ml - sufentanil citrate 7.48 µg/ml - sufentanil

Sufentanil Viatris 50 µg/ml inj. sol. i.v./epidur. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sufentanil viatris 50 µg/ml inj. sol. i.v./epidur. amp.

viatris gx bv-srl - sufentanil citrate 74,85 µg/ml - eq. sufentanil 50 µg/ml - solution for injection - 50 µg/ml - sufentanil citrate 74.85 µg/ml - sufentanil

Sufentanil Viatris 5 µg/ml inj. sol. i.v./epidur. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sufentanil viatris 5 µg/ml inj. sol. i.v./epidur. amp.

viatris gx bv-srl - sufentanil citrate 7,48 µg/ml - eq. sufentanil 5 µg/ml - solution for injection - 5 µg/ml - sufentanil citrate 7.48 µg/ml - sufentanil

REMIFENTANIL HYDROCHLORIDE injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

remifentanil hydrochloride injection, powder, lyophilized, for solution

fresenius kabi usa, llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil hydrochloride (hcl) for injection is indicated for intravenous (iv) administration: - as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. - for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. - as an analgesic component of monitored anesthesia care in adult patients. remifentanil hcl is contraindicated: - for epidural or intrathecal administration due to the presence of glycine in the formulation [see nonclinical toxicology (13)] . - in patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see adverse reactions (6.2)] . risk summary prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to inform a drug-associated risk f

REMIFENTANIL HYDROCHLORIDE injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

remifentanil hydrochloride injection, powder, lyophilized, for solution

navinta llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil hydrochloride for injection is indicated for intravenous (iv) administration: - as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. - for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. - as an analgesic component of monitored anesthesia care in adult patients. remifentanil hydrochloride for injection is contraindicated: - for epidural or intrathecal administration due to the presence of glycine in the formulation [see nonclinical toxicology (13)] . - in patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see adverse reactions (6.2)] . prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant

Remifentanil 1 mg powder for concentrate for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

remifentanil 1 mg powder for concentrate for solution for injection or infusion

pinewood laboratories ltd, - remifentanil hydrochloride - powder for concentrate for solution for injection/infusion - 1 milligram(s) - opioid anesthetics; remifentanil

Remifentanil 2 mg powder for concentrate for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

remifentanil 2 mg powder for concentrate for solution for injection or infusion

pinewood laboratories ltd, - remifentanil hydrochloride - powder for concentrate for solution for injection/infusion - 2 milligram(s) - opioid anesthetics; remifentanil

Remifentanil 5 mg powder for concentrate for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

remifentanil 5 mg powder for concentrate for solution for injection or infusion

pinewood laboratories ltd, - remifentanil hydrochloride - powder for concentrate for solution for injection/infusion - 5 milligram(s) - opioid anesthetics; remifentanil